Literature DB >> 10791217

Postoperative complications of repeat hepatectomy for liver metastasis from colorectal carcinoma.

M Aramaki1, K Kawano, T Kai, A Sasaki, T Ohno, K Tahara, Y Takeuchi, T Yoshida, S Kitano.   

Abstract

BACKGROUND/AIMS: When a repeat hepatectomy is possible, it is the most effective treatment modality for recurrent colorectal liver metastasis. The aim of this study was to evaluate the surgical risks of repeat hepatectomy for liver metastasis from colorectal carcinoma.
METHODOLOGY: Between 1986 and 1996, 60 patients with hepatic metastasis from colorectal carcinoma underwent surgery in the Department of Surgery I, Oita Medical University. Ten of them underwent a repeat hepatectomy. The cases of these 10 patients were studied retrospectively; in particular, postoperative complications and intraoperative blood loss were compared between the initial and second operation.
RESULTS: During the second surgery, recurrence was detected adjacent to the hepatic stump in 9 of the 10 patients. During the initial surgery, 6 underwent non-anatomic resections, and 4 had anatomic resection, including 1 extended lobectomy, 1 lobectomy, and 2 segmentectomies. For the second surgery, 3 had anatomic resections, including 2 lobectomies, and 1 segmentectomy, and 7 underwent non-anatomic resections. There were no mortalities during the initial or second operation. There was no morbidity following the initial surgeries and 7 postoperative complications (intraabdominal abscess, 4 cases; biloma, 3 cases) following the second surgeries. Mean blood loss during the second operation (1044 mL) was significantly greater than during the initial operation (561 mL).
CONCLUSIONS: The present results show that repeat hepatectomy for recurrent liver metastasis from colorectal carcinoma resulted in significantly greater intraoperative blood loss and postoperative complications than those of the initial surgeries. The blood loss and complications in the second operation, the one for the recurrence, were directly associated with the fact that the recurrence was so close to the hepatic stump. Since the resection line in the second surgery was adjacent to the hepatic hilus, resection of the lesion caused much more injury to the main bile duct and main portal vein than that caused by the.

Entities:  

Mesh:

Year:  2000        PMID: 10791217

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Liver abscess after liver metastasectomy is a poor prognostic factor in patients with colorectal cancer.

Authors:  Yen-Ning Hsu; Chia-Jen Liu; Jen-Kou Lin; Wei-Shone Chen; Tzu-Chen Lin; Shung-Haur Yang; Jeng-Kai Jiang; Shih-Ching Chang; Yuan-Tzu Lan; Chun-Chi Lin; Chueh-Chuan Yen; Jin-Huang Liu; Cheng-Hwai Tzeng; Hao-Wei Teng
Journal:  J Gastrointest Surg       Date:  2011-07-23       Impact factor: 3.452

2.  Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Authors:  Narendra Battula; Dimitrios Tsapralis; David Mayer; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Simon Bramhall; Darius Mirza; Ravi Marudanayagam
Journal:  HPB (Oxford)       Date:  2013-03-27       Impact factor: 3.647

3.  Liver resection for colorectal metastases: the third hepatectomy.

Authors:  René Adam; Gérard Pascal; Daniel Azoulay; Kuniya Tanaka; Denis Castaing; Henri Bismuth
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

4.  Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

Authors:  Mechteld C de Jong; Skye C Mayo; Carlo Pulitano; Serena Lanella; Dario Ribero; Jennifer Strub; Catherine Hubert; Jean-François Gigot; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452

5.  RE-HEPATECTOMY MEANS MORE MORBIDITY? A MULTICENTRIC ANALYSIS.

Authors:  Luiza Basilio; Klaus Steinbrück; Reinaldo Fernandes; Marcelo D'Oliveira; Renato Cano; Hanna Vasconcelos; Daniel Barbosa; Marcelo Enne
Journal:  Arq Bras Cir Dig       Date:  2022-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.